Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bezafibrate for cholestatic itch in sclerosing cholangitis and primary biliary cholangitis
NL-OMON42182Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of bezafibrate in cholestatic disease, primary biliary cholangitis (PBC), Primary Sclerosing Cholangitis (PSC) and 1 more, sponsored by Amsterdam University Medical Center. Primary endpoint: Itch intensity score on visual analogue scale. Started Oct 2015; status: recruiting.
02
Drugs
bezafibrate
03
Conditions
cholestatic diseaseprimary biliary cholangitis (PBC)Primary Sclerosing Cholangitis (PSC)secondary sclerosing cholangitis (SSC)
Beyond the preview
Go deeper on NL-OMON42182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42182.